|
Many of the early regenerative therapies will be expensive in the West, but could be reasonable cost in Asia. An example of this is bypass surgury. Bypass surgury is typically USD90,000 or so in the U.S. Performed in Singapore (by surgeons just as competent as thos in the U.S.) such surgury is about USD11,000-15,000. Its lower still in Malaysia and, presummably, India.
Such medical "outsourcing" is already becoming a reality. The BBC recently had an article on thier website about this. I know people who have gone to Taiwan and Thailand for elective (i.e. cosmetic) surgury.
I fully expect to be hopping on the plane for Asia when the time comes for me to undergo "regenerative" therapy. I have never expected that insurance will pay for this stuff. Being self-employed, I have only catastrophic insurance anyways.
I do not expect "regenerative" therapy to involve the growing of organs in a chamber, then transplant of such organs into you. This is too primative and expensive. At worst, such therapy will involve the injection of stem-cells (either embryonic or adult) into you be shot or, morel likely, "nanotech" based drug delivery technique (several start-ups in both U.S. and Asia have developed this already).
More likely, compounds will be developed that will "immortalize" and or "turn-on" stem-cell reservours that already exist within your body, which will result in "in-sitsu" regeneration of your body. The compounds will be delivered by the same "nanotech" delivery systems that the stem-cells would be.
Not only will this be MUCH cheaper (can be done on out-patient basis, for one thing) but is much more elegant than barbaric practices such as surgury.
Yes, this is good 20 years away, but I really do believe this is possible. For more information on "nanotech" delivery systems, scan through the Nanotech Business Alliance company directory. There are a fair number of start-ups developing this now.
The other reason why Asia will be the best place for these therapies is that most people there have less money to spend on medical treatment and there is no "single, third party payer system" that makes medical technology so expensive in the West. A therapy has to be affordable in order to succeed in the marketplace. Also, Asia has, or will have, the largest global market for regenerative therapies anyways.
BTW, Aubrey de Grey is well aware of these aspects of Asia, with regards to development and commercialization of anti-aging therapies.
[Posted by: Kurt at March 24, 2004 5:04 PM]
|